Lessons from Navigating AI in Biotechnology

TL;DR Summary
Naren Tallapragada, CEO of Tessel Bio, discusses the limitations and potential of AI in biology, emphasizing that while AI models like AlphaFold have advanced protein folding predictions, they cannot yet fully model biological systems such as cells or tissues. He highlights the importance of real data, as seen in successful startups like Fauna Bio and Enveda, which have built extensive databases to support their AI models. Tallapragada advocates for "augmented intelligence," where AI assists in guiding experiments, as a practical approach in drug discovery.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
92%
1,099 → 84 words
Want the full story? Read the original article
Read on STAT